Ibaraki, Japan

Michihiro Takai

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michihiro Takai. Retrieved from https://idiyas.com/inventor/michihiro-takai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 14.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michihiro Takai: Innovator in Dipeptide Nitriles

Introduction

Michihiro Takai is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly with his work on dipeptide nitriles. His innovative approach has led to the development of a patent that showcases his expertise and creativity.

Latest Patents

Takai holds a patent for dipeptide nitriles, which is a testament to his research and development efforts. This patent is a crucial part of his contributions to the pharmaceutical industry, highlighting his role as an inventor. He has 1 patent to his name, reflecting his focused work in this specialized area.

Career Highlights

Currently, Michihiro Takai is employed at Novartis AG, a leading global healthcare company. His role at Novartis allows him to further his research and collaborate with other experts in the field. His career is marked by a commitment to innovation and the advancement of medical science.

Collaborations

Throughout his career, Takai has worked alongside talented colleagues, including Eva Altmann and Claudia Betschart. These collaborations have enriched his work and contributed to the success of various projects within the company.

Conclusion

In summary, Michihiro Takai is a distinguished inventor whose work on dipeptide nitriles has made a significant impact in the pharmaceutical industry. His dedication to innovation and collaboration continues to drive advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…